Cleerly, a leader in AI-based cardiovascular imaging, presented new, late-breaking science from the international CONFIRM2 Registry at the Global CVCT Scientific Program 2025 in Washington, DC. This ...
Data from FDA-advised study demonstrates Lumee™ Oxygen tissue monitoring is a safe and effective long-term method in PAD patients and will support potential FDA submission; strongly correlates with ...
WELL, WE START WITH LATE BREAKING NEWS, NEW DETAILS ABOUT THE DEADLY SHOOTING ON CAMPUS AT KENTUCKY STATE UNIVERSITY. WHY SOME STUDENTS ARE BEING CALLED HEROES. AND THE RAIN WAS FALLING AS DOZENS CAME ...
BOSTON--(BUSINESS WIRE)--Kelonia Therapeutics, Inc., a clinical-stage biotechnology company pioneering in vivo gene delivery, today announced that its first results from the ongoing inMMyCAR study, a ...
IRVINE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced results from an ...
Multiple backstage notes and early spoilers are circulating ahead of tonight’s AEW Full Gear pay-per-view at the Prudential Center in Newark, NJ. Here’s the latest being discussed, courtesy of ...
Washington — Former FBI Director James Comey is seeking to dismiss the criminal case against him because of what he claims were "fundamental errors" in the grand-jury process and interim U.S. Attorney ...
NEW ORLEANS, LA—The diabetes drug metformin can reduce recurrence of atrial arrhythmia for patients with overweight and obesity undergoing catheter ablation even if they’re not diabetic, results from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback